Roxbury Financial’s Pfizer PFE Stock Holding History

Roxbury Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67K	Sell	2,781 -1,840	-40%	-$48.1K	0.05%	178
2026 Q1	$130K	Sell	4,621 -2,349	-34%	-$62.5K	0.12%	121
2025 Q4	$174K	Sell	6,970 -961	-12%	-$24.2K	0.16%	101
2025 Q3	$202K	Sell	7,931 -15	-0.2%	-$370	0.19%	88
2025 Q2	$193K	Sell	7,946 -3,481	-30%	-$81.2K	0.19%	88
2025 Q1	$302K	Sell	11,427 -3,793	-25%	-$99.3K	0.3%	65
2024 Q4	$399K	Buy	+15,220	New	+$413K	0.38%	57

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Roxbury Financial's PFE Position: Q2 2026 in Review

Roxbury Financial reduced its Pfizer (PFE) stake by 40% in Q2 2026, selling an estimated $48.1K and leaving 2,781 shares worth $67K. The position accounts for 0.05% of the portfolio, ranked #178.

Roxbury Financial first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $399K in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Roxbury Financial held 2,781 shares of Pfizer worth $67K as of Q2 2026.
Roxbury Financial sold 1,840 Pfizer shares in Q2 2026, an estimated $48.1K.
Pfizer made up 0.05% of Roxbury Financial's portfolio in Q2 2026, its #178 holding.
Roxbury Financial first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Roxbury Financial's Pfizer position peaked at $399K in Q4 2024.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Roxbury Financial's 13F filing for Q2 2026, filed 1 Jul 2026.